Key Metrics 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Zandu Realty Ltd. - (Amalgamated) (ZANDUREALT)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506720 NSE: ZANDUREALT Pharmaceuticals & Drugs | Small Cap | Zandu Realty-(Amalga Share Price
BSE Share Price
Not Listed
Not Listed
Zandu Realty Ltd. - (Amalgamated) (ZANDUREALT)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506720 NSE: ZANDUREALT Pharmaceuticals & Drugs | Small Cap | Zandu Realty-(Amalga Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹153 Cr.
Current Price
₹0
52-Week Low / High
₹1,850 / 1,951
TTM EPS
₹156.6
TTM Sales
₹104 Cr.
Book Value per Share
₹285.4
P/E Ratio
12.10
Industry PE
55
Price to Book (P/B)
6.64
Price to Sales (P/S)
1.48
EV/EBITDA
5.64
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
26.93%
Return on Capital Employed (ROCE)
33.53%
Return on Assets (ROA)
16.07%
Operating Profit Margin
19.1%
Net Profit Margin
13.47%
Gross Profit Margin
22.4%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
-40.83%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
-23.9%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-15.45%
Asset Quality
Promoter Holding
35.51%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹15 Cr.
Equity
₹8.1 Cr.
Face Value
₹100
All Time Low / High
₹650.00 / 24643.20
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation ⓘ
| Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 33.7% | 42.4% | 5.6% | 3.3% | -138% | 2.9% | 54.2% | 52% | 5.7% | 4.2% | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 136 | 87.3 | 0 | 0 | 70 | 0 | 29 | 86.9 | 8.7 | 5.1 | 0 |
| Sales YoY Gr. | - | -35.9% | -100% | NA | NA | -100% | NA | 199.3% | -90% | -40.8% | - |
| Adj EPS ⓘ | 196.4 | 171 | 16.4 | 11.3 | -871.6 | 16.7 | 476.6 | 797.1 | 87.4 | 64.2 | 78.3 |
| YoY Gr. | - | -12.9% | -90.4% | -30.6% | -7785.6% | NA | 2750.4% | 67.2% | -89% | -26.5% | - |
| BVPS (₹) ⓘ | 962.9 | 285.4 | 302.6 | 314 | 887 | 903.7 | 1,380.3 | 2,177.3 | 2,264.8 | 2,329 | 2,303.5 |
| Adj Net Profit ⓘ | 15.8 | 13.8 | 1.3 | 0.9 | -70.3 | 1.4 | 38.4 | 64.3 | 7.1 | 5.2 | 6 |
| Cash Flow from Ops. ⓘ | 22.8 | 13.5 | 0 | -1.4 | 72.2 | -5 | 65.6 | 7 | -3 | 6 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 1.9 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | -30.5% | -40.7% | -43.9% | -40.8% | ||||
| Adj EPS ⓘ | -11.7% | NA | -48.7% | -26.5% | ||||
| BVPSⓘ | 10.3% | 21.3% | 19.1% | 2.8% | ||||
| Share Price | - | - | - | - | ||||
Key Financial Parameters ⓘ
| Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 21.7 | 27.4 | 5.6 | 0.6 | -29.9 | 0.7 | 18.6 | 31.4 | 3.6 | 2.6 | 3.4 |
| Op. Profit Mgn % ⓘ | 17.1 | 20.8 | 0 | 0 | -102.1 | 0 | 77.3 | -3.5 | -39.2 | -72.6 | -1607.6 |
| Net Profit Mgn % ⓘ | 11.6 | 15.8 | 0 | 0 | -100.4 | 0 | 132.3 | 74 | 81.3 | 101 | 6312.6 |
| Debt to Equity ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | 0 | 0.1 | - |
| Working Cap Days ⓘ | 86 | 73 | 0 | 0 | 1,255 | 0 | 1,574 | 492 | 3,182 | 2,998 | 9,338 |
| Cash Conv. Cycle ⓘ | 9 | 4 | 0 | 0 | 941 | 0 | 1,369 | 281 | 892 | 969 | 8,685 |
Valuation of Zandu Realty-(Amalga - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'02 | Mar'03 | Mar'07 | Mar'08 | Mar'09 |
|---|---|---|---|---|---|
| Sales | 102.80 | 100.66 | 144.89 | 168.01 | 103.57 |
| Operating Expenses ⓘ + | 87.66 | 88.25 | 123.55 | 143.49 | 84.92 |
| Operating Profit ⓘ | 15.13 | 12.41 | 21.34 | 24.52 | 18.66 |
| Operating Profit Margin (%) | 14.7% | 12.3% | 14.7% | 14.6% | 18.0% |
| Other Income ⓘ + | 1.68 | 2.73 | 4.73 | 4.32 | 8.34 |
| Interest ⓘ | 2.71 | 1.36 | 0.49 | 1.01 | 2.40 |
| Depreciation ⓘ | 4.61 | 3.87 | 3.41 | 3.39 | 4.78 |
| Profit Before Tax ⓘ | 9.49 | 9.91 | 22.17 | 24.43 | 19.83 |
| Tax ⓘ | 2.46 | 2.42 | 6.60 | 7.93 | 5.88 |
| Profit After Tax | 7.03 | 7.48 | 15.58 | 16.50 | 13.95 |
| PAT Margin (%) | 6.8% | 7.4% | 10.8% | 9.8% | 13.5% |
| Adjusted EPS (₹) | 80.0 | 78.6 | 201.6 | 204.4 | 156.6 |
| Dividend Payout Ratio (%) | 25% | 25.50% | 44.60% | 36.70% | 0% |
| PARTICULARS | Mar'02 | Mar'03 | Mar'07 | Mar'08 | Mar'09 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 36.38 | 42.50 | 71.48 | 80.64 | 23.01 | ||||||
| Debt + | 10 | 1.77 | 8.88 | 28.90 | 0 | ||||||
| Minority Interest | 0.86 | 0.91 | 0.13 | 0.13 | 0 | ||||||
| Trade Payables | 13.87 | 8.70 | 18.97 | 21.60 | 0.05 | ||||||
| Others Liabilities ⓘ | 12.55 | 14.59 | 11.81 | 18.28 | 1.04 | ||||||
| Total Liabilities ⓘ | 73.65 | 68.48 | 111.26 | 149.55 | 24.11 | ||||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 32.61 | 29.16 | 24.43 | 21.90 | 0.02 | ||||||
| CWIP ⓘ | 0.09 | 0 | 19.41 | 57.48 | 0 | ||||||
| Investments ⓘ | 0.85 | 1.15 | 7.72 | 13.06 | 22.49 | ||||||
| Inventories | 21.40 | 18.20 | 28.80 | 25.60 | 0 | ||||||
| Trade Receivables | 6.03 | 5.24 | 4.37 | 5.20 | 0 | ||||||
| Cash Equivalents | 1.76 | 1.27 | 13.13 | 13.08 | 0.65 | ||||||
| Others Assets ⓘ | 10.92 | 13.46 | 13.39 | 13.24 | 0.95 | ||||||
| Total Assets ⓘ | 73.65 | 68.48 | 111.26 | 149.55 | 24.11 | ||||||
| PARTICULARS | Mar'02 | Mar'03 | Mar'07 | Mar'08 | Mar'09 |
|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 19.78 | 10.56 | 19.96 | 23.73 | 13.04 |
| Cash Flow From Investing Activity ⓘ + | -1.05 | -0.41 | -15.30 | -37.40 | -14.88 |
| Cash Flow From Financing Activity ⓘ + | -20.68 | -10.64 | -4.89 | 13.63 | -4.72 |
| Net Cash Flow ⓘ | -1.95 | -0.49 | -0.24 | -0.04 | -6.55 |
| PARTICULARS | Mar'02 | Mar'03 | Mar'07 | Mar'08 | Mar'09 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 19.32 | 18.97 | 27.33 | 21.69 | 26.93 | |||||
| ROCE (%) | 26.31 | 24.86 | 36.36 | 26.8 | 33.53 | |||||
| Asset Turnover Ratio | 1.54 | 1.59 | 1.83 | 1.43 | 1.26 | |||||
| PAT to CFO Conversion(x) | 2.81 | 1.41 | 1.28 | 1.44 | 0.93 | |||||
| Working Capital Days | ||||||||||
| Receivable Days | 19.40 | 18.20 | 10.70 | 9.30 | 0 | |||||
| Inventory Days | 68.70 | 64 | 52.30 | 53.10 | 0 | |||||
| Payable Days | 172.90 | 173.20 | 118.80 | 127.80 | 136.60 | |||||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Zandu Realty Ltd. - (Amalgamated) FAQs
The current trading price of Zandu Realty-(Amalga on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Zandu Realty-(Amalga stood at ₹152.9 Cr
The latest P/E ratio of Zandu Realty-(Amalga as of 31-Dec-1969 is 24.21.
The latest P/B ratio of Zandu Realty-(Amalga as of 31-Dec-1969 is 0.82.
The 52-week high of Zandu Realty-(Amalga is ₹1,950.9 and the 52-week low is ₹1,850.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Zandu Realty-(Amalga is ₹0.10 ( Cr.) .
Data is not available for this company.
The key valuation ratios of Zandu Realty Ltd. - (Amalgamated)'s currently when compared to its past seem to suggest it is in the Undervalued zone.
No data found
About Zandu Realty Ltd. - (Amalgamated)
Zandu Pharmaceutical works name was changed to Zandu Realty from March 10, 2010. At present, the company is a multi-product entity, comprising a group of companies. Zandu projects a sale of nearly Rs. 2,000/- Million by 2000 A.D.
It was listed in 1919; is engaged in offering ayurvedic healthcare medicines.
Zandu manufactures a wide range of ayurvedic medicine specialised in area of rheumatology, gynaecology and CNS (Central nervous system).
Using 200 medicinal plants and their extracts it manufactures 300 healthcare products. The company markets its products under the brand name Zandu.
The company exports herbal health care products to U.S.A, Europe and Asian countries.
The chemical division is located at Ankleshwar that manufactures bulk drugs and intermediates. The cosmetics division manufactures wide range of skin care products such as lotion, soaps, shampoo, creams, etc. It markets the cosmetic products under name Z-naree.
It manufactures products such as zandu balm, brento, kesari-jivan, zandu honey, triphala churna, sudarshan, rhumasyl oil, gulbahar, chandra prabhavati, etc.
ZPWL has formed joint venture with Gujarat Agro Industries Corporation to manufacture glycyrrhiza extract from a vegetable plant-extraction project.
In the year 1989 Leopard Investments Private Limited has become the subsidiary of ZPWL.
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
